Clinical presentation, diagnosis, and long-term outcome of 29 patients with Wilson's disease

被引:0
作者
Rodrigo Agudo, J. L. [1 ]
Valdes Mas, M. [1 ]
Vargas Acosta, A. M. [1 ]
Ortiz Sanchez, M. L. [1 ]
Gil del Castillo, M. L. [2 ]
Carballo Alvarez, L. F. [1 ]
Pons Minano, J. A. [1 ]
机构
[1] Hosp Univ Virgen Arrixaca, Serv Aparato Digest, Murcia 30120, Spain
[2] Hosp Univ Virgen Arrixaca, Lab Bioquim, Murcia 30120, Spain
关键词
Wilson's disease; clinical presentation; long-term outcome; copper;
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objective: to analyze the clinical characteristics, treatment, and follow-up of a cohort of 29 patients with Wilson's disease (WD) within the region of Murcia. Patients and method: we reviewed the medical records of 29 cases of WD (mean age. 20.3 +/- 13.4 years) diagnosed during the last 16 years. Results: the most frequent reason for consultation was upon discovering a high transaminase level in almost half the patients, followed by tremors or dystonia in 17% of patients, respectively. A Kayser-Fleischer ring was observed in 17/29 (58.6%) of patients (100% of patients with pure neurological involvement and 35% of patients with pure clinical hepatic disease;, p < 0.001). Blood copper levels not associated with ceruloplasmin as well as cupruria were notably superior in patients with neurological symptoms and in those with liver cirrhosis at the time of diagnosis. Patient clinical symptoms remained stable with D-penicillamine or trientine. or improved during the observation period, for 18 out of 29 patients (62%), while 11 out of 29 patients (38%) got worse. Conclusions: in our region patients with WD are diagnosed at a younger age, and in most cases for hepatic disease. Patients with neurological disease o liver cirrhosis had a high level of free copper not associated to ceruloplasmin and cupruria. The disease had a favorable evolution in all patients but those diagnosed with hepatic disease or advanced neurological disease.
引用
收藏
页码:456 / 461
页数:6
相关论文
共 27 条
  • [1] Wilson's disease
    Ala, Aftab
    Walker, Ann P.
    Ashkan, Keyoumars
    Dooley, James S.
    Schilsky, Michael L.
    [J]. LANCET, 2007, 369 (9559) : 397 - 408
  • [2] BEARN AG, 1960, ANN HUM GENET, V24, P33
  • [3] Clinical and molecular characterization of Wilson disease in Spanish patients
    Brage, Antonio
    Tome, Santiago
    Garcia, Aranzazu
    Carracedo, Angel
    Salas, Antonio
    [J]. HEPATOLOGY RESEARCH, 2007, 37 (01) : 18 - 26
  • [4] Recognition, diagnosis, and management of Wilson's disease
    Brewer, GJ
    [J]. PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 2000, 223 (01): : 39 - 46
  • [5] Wilson's disease: clinical management and therapy
    Brewer, GJ
    Askari, FK
    [J]. JOURNAL OF HEPATOLOGY, 2005, 42 : S13 - S21
  • [6] Bruguera M, 2006, Gastroenterol Hepatol, V29, P29, DOI 10.1157/13083259
  • [7] CASTELLANO G, 1992, REV CLIN ESP, V190, P223
  • [8] ATP7B mediates vesicular sequestration of copper: Insight into biliary copper excretion
    Cater, MA
    La Fontaine, S
    Shield, K
    Deal, Y
    Mercer, JFB
    [J]. GASTROENTEROLOGY, 2006, 130 (02) : 493 - 506
  • [9] THE EFFECTS OF BAL IN HEPATOLENTICULAR DEGENERATION
    CUMINGS, JN
    [J]. BRAIN, 1951, 74 (01) : 10 - 22
  • [10] Diagnosis and phenotypic classification of Wilson disease
    Ferenci, P
    Caca, K
    Loudianos, G
    Mieli-Vergani, G
    Tanner, S
    Sternlieb, I
    Schilsky, M
    Cox, D
    Berr, F
    [J]. LIVER INTERNATIONAL, 2003, 23 (03) : 139 - 142